Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?The Motley Fool • 05/28/24
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supplyCNBC • 05/24/24
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesPRNewsWire • 05/24/24
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 05/23/24
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&ACNBC • 05/23/24
Eight Massive ETFs With Billions In Assets Are Beating The S&P 500Investors Business Daily • 05/23/24
Amid ‘Ozempic babies' questions, women account for more than 75% of young adults taking GLP-1 drugs, study findsMarket Watch • 05/22/24